Nova Mentis Life Science (NMLSF)
OTHER OTC:NMLSF
Holding NMLSF?
Track your performance easily

Nova Mentis Life Science (NMLSF) Financial Statements

17 Followers

Nova Mentis Life Science Financial Overview

Nova Mentis Life Science's market cap is currently ―. The company's EPS TTM is $-0.003; its P/E ratio is -3.23; Nova Mentis Life Science is scheduled to report earnings on November 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -90.58KC$ -144.38KC$ -209.56KC$ -184.06KC$ -302.79K
EBITDAC$ -90.00KC$ -143.80KC$ -210.29KC$ -181.86KC$ -302.06K
Net Income Common StockholdersC$ -90.58KC$ -144.38KC$ -209.56KC$ -184.06KC$ -302.79K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 12.06KC$ 21.82KC$ 8.09KC$ 24.44KC$ 17.44K
Total AssetsC$ 26.35KC$ 40.10KC$ 31.06KC$ 53.89KC$ 61.48K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -12.06KC$ -21.82KC$ -8.09KC$ -24.44KC$ -17.44K
Total LiabilitiesC$ 1.07MC$ 995.08KC$ 841.66KC$ 654.93KC$ 478.46K
Stockholders EquityC$ -1.05MC$ -954.98KC$ -810.60KC$ -601.04KC$ -416.98K
Cash Flow-
Free Cash FlowC$ -9.76KC$ -46.27KC$ 251.82KC$ -261.18KC$ -96.50K
Operating Cash FlowC$ -9.76KC$ -46.27KC$ 251.82KC$ -261.18KC$ -96.50K
Investing Cash Flow-----
Financing Cash Flow-C$ 60.00KC$ -19.10KC$ 19.10K-
Currency in CAD

Nova Mentis Life Science Earnings and Revenue History

Nova Mentis Life Science Debt to Assets

Nova Mentis Life Science Cash Flow

Nova Mentis Life Science Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis